Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(25.0%)
Early Phase 1
1(25.0%)
Phase 2
1(25.0%)
N/A
1(25.0%)
4Total
Phase 3(1)
Early Phase 1(1)
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04582708Phase 2Completed

Use of NERv's Inline Device as an Early Diagnostic Method for Postoperative Complications

Role: lead

NCT05994625Phase 3Active Not Recruiting

Economic Evaluation of Stream™ Platform

Role: lead

NCT06541431Recruiting

Analytical Validation of Stream™ Platform

Role: lead

NCT06522061Not ApplicableNot Yet Recruiting

Evaluating the Effective and Safe Use of Stream™ Platform

Role: lead

NCT04253028Early Phase 1Completed

Use of NERv's Inline Device as an Early Diagnostic Method for Anastomotic Leak.

Role: lead

All 5 trials loaded